![Malte Greune](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malte Greune
Chief Operating Officer at
CUREVAC
Profile
Malte Greune occupies the position of Chief Operating & Production Officer at CureVac NV. In the past he held the position of VP-Cartridges, Devices & Insulin Technology Group at Sanofi-Aventis Deutschland GmbH. He received a doctorate from Universität zu Köln, an undergraduate degree from the University of Trier and an MBA from Clark University.
Malte Greune active positions
| Companies | Position | Start |
|---|---|---|
| CUREVAC | Chief Operating Officer | 01/07/2021 |
Former positions of Malte Greune
| Companies | Position | End |
|---|---|---|
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Corporate Officer/Principal | - |
Training of Malte Greune
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Clark University
 Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Trier
 University of Trier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Stock Market
- Insiders
- Malte Greune
